Company: RGNT
Filing Date: 2025-09-30
Form Type: F-1/A
Source: 0001213900-25-093302
Chunk: 297

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-09-30
Form: F-1/A
Chunk 297
---
April          
 2025 Loan Agreements”), pursuant to which the Company obtained bridge loans at the         
 amount of $200 from the lenders thereto including certain related parties, including the   
 Company’s chairman of the board of directors and a director nominee. The April 2025        
 Loans shall bear interest at 8% per annum until maturity and the Company agreed to pay the 
 lenders an additional risk premium equal to 50% of their respective loan amount. Regarding 
 extension of Maturity Date, see also Note 9.                                               |

The April 2025 Loan’s maturity date
is the earlier of August 31, 2025, or the date of consummation of a Qualified IPO (consummation of an IPO on NYSE or the NASDAQ for a
total offering of no less than $6,000). Furthermore, upon the occurrence of a Qualified IPO, the April 2025 Loan lenders, shall be granted
warrants to purchase such number of Ordinary Shares equal to two times their respective loan amount in addition to the risk premium based
on a price per share equal to 75% of the lowest price per share of the Ordinary Shares during the first five trading days following the
consummation of such IPO. As of June 30, 2025, the loan balance, accrued interest and accrued risk premium was approximately $253. The
risk premium was accounted as additional interest to be paid upon maturity date, and the Company amortized such interest expense during
the term of the loan using the effective interest method.

The following table presents the
movement in short-term loans:

| Balance as of December 31, 2024   |     | $ |   573 |
| Receipt of a short-term loans     |     |   |   300 |
| Accrued interest and amortization 
 of short-term loans’ premium risk |     |   |   179 |
| Balance as of June 30, 2025       |     | $ | 1,052 |

| Balance as of December 31, 2023                        |     | $ |  210 |   |
| Accrued interest and amortization of short-term loans’ 
 premium risk                                           |     |   |  115 |   |
| Loan repayment                                         |     |   | (325 | ) |
| Receipt of a short-term loans                          |     |   |  150 |   |
| Balance as of June 30, 2024                            |     | $ |